DT MedTech Secures CE Marking and Begins Active Distribution of Hintermann Series H3™ Lower Extremity Medical Devices

August 15, 2016 (Baltimore, MD) – DT MedTech, LLC (DTMT) announced today that having secured CE Marking for the Hintermann Series H3™ total ankle replacement devices, in compliance with mandatory European Directives, they are now actively selling and distributing their products outside the USA.

The DTMT Hintermann Series products for the lower extremity include: (1) Hintermann Series H3™ three-piece Total Ankle Replacement prosthesis, comprising the Standard, Sensitive, and Revision systems (formerly known as the HINTEGRA Total Ankle Replacement prosthesis); (2) Kalix® II subtalar arthrodesis implant to treat flatfoot deformities; and (3) instrumentation to support the implantable devices. Developed by prominent surgeon, Prof. Beat Hintermann, this Total Ankle Replacement system is a proven, dominant player in the ankle replacement market outside the USA with over 15 years of solid clinical efficacy.

The Hintermann Series product line has been approved for use in the following countries: Australia, Austria, Belgium, Canada, Costa Rica, Czech Republic, Denmark, Finland, France, Germany, Ireland, Italy, South Korea, Latvia, Lithuania, Luxembourg, Malaysia, Netherlands, New Zealand, Panama, Portugal, Russia, Sweden, Switzerland, Thailand, UAE, and the United Kingdom.

Distribution channels have been secured to handle products in approved countries, with HealthLink Europe BV delivering the majority of logistics outside the USA.

David Reicher, President and Chief Executive Officer of DTMT, stated, “Through hard work and sheer determination, everyone at DT MedTech can finally see the successful results of their efforts. We thank them all. Any questions our customers may have should be directed to Ms. Jeannie Sarda at info@DTMedTech.com or by calling her at 877-494-2252, in the USA. In addition, customers can contact DT MedTech at CustomerService@DTMedTech.com and DT-MedTech@HealthLinkEurope.com or by calling +31(0)73-3032537, outside the USA.”

DT MedTech Assumes Production and Distribution of Hintermann Series™ Lower Extremity Medical Devices

April 29, 2016 (Baltimore, MD) – DT MedTech, LLC (DTMT) announced today that on May 1, 2016, it will officially take over all production, sales, and worldwide distribution of the Hintermann Series™ lower extremity device product line. Developed by prominent surgeon, Prof. Beat Hintermann, the line includes: (1) Hintermann Series H3™ 3-piece Total Ankle Replacement prosthesis, including the Standard and Revision models (formerly known as the HINTEGRA Total Ankle Replacement prosthesis); (2) the Kalix® II, a subtalar arthroereisis implant to treat flatfoot deformities; and (3) instrumentation to support the implantable devices.

Current manufacturers who have been producing the Hintermann Series products for the past 10 years, will continue to manufacture all products for DTMT, and Healthlink Europe has been contracted to handle the majority of logistics outside of the United States, beginning immediately.

David Reicher, president and chief executive officer of DTMT, stated, “Everyone at DT MedTech is excited to take ownership of this superior, clinically-proven line of the Hintermann Series lower extremity medical devices, and eager to start producing and distributing these life-altering products outside the US.”

“We especially want to thank everyone involved for all of their hard work in making the transition as seamless as possible. We understand there may be issues as we embark on this journey and ask that any questions our customers may have, be directed to Jeannie Sarda at info@dtmedtech.com, or by calling her at 410-494-4994, ext. 250, in the US.”

DT MedTech Acquires Worldwide Ownership of Hintermann Series of Lower Extremity Replacement and Revision Medical Devices

March 3, 2016 (Baltimore, MD) – DT MedTech, LLC (DTMT) announced today that it has successfully completed the acquisition of ownership of the Hintermann Series lower extremity device product line. Developed by prominent surgeon, Professor Beat Hintermann, this exceptional product line includes: (1) the Hintermann Series H3™ 3-piece Total Ankle Replacement prosthesis (formerly known as the HINTEGRA Total Ankle Replacement prosthesis), including a revision platform, and a system available for patients with sensitivities to Cobalt-Chrome alloys; (2) the Kalix® II, a subtalar arthroereisis implant to treat flatfoot deformities; and (3) instrumentation and consumables to support the implantable devices.

TARimage

As of May 1, 2016, DTMT will have the exclusive rights to manufacture, distribute, import, export, market, and sell the entire Hintermann Series product line. Current manufacturers, who have been producing the Hintermann Series products for the past 10 years, will continue to manufacture all products for DTMT, and Healthlink Europe will handle the majority of logistics outside of the United States. Currently, the product line is only available outside of the US.

Dr. David Reicher, president and chief executive officer of DTMT, stated, “Our ownership of this superior, clinically-proven line of the Hintermann Series medical devices marks an important milestone for DT MedTech, as we begin to position ourselves as a global leader in lower extremity surgical solutions. Working diligently alongside Professor Beat Hintermann, we plan to expand worldwide distribution of the Hintermann Series H3 Total Ankle Replacement and will introduce Professor Hintermann’s innovative, 2-piece total ankle replacement device in the very near future. We want to assure all surgeons who currently use these products that the newly acquired devices will remain exactly the same in structure and materials. Additionally, we foresee no disruption in terms of product availability.”